- Home
- BCC vs CPRX Comparison
BCC vs CPRX Comparison
Compare BCC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCC
- CPRX
- Stock Information
- Founded
- BCC 2004
- CPRX 2002
- Country
- BCC United States
- CPRX United States
- Employees
- BCC N/A
- CPRX N/A
- Industry
- BCC RETAIL: Building Materials
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BCC Consumer Discretionary
- CPRX Health Care
- Exchange
- BCC Nasdaq
- CPRX Nasdaq
- Market Cap
- BCC 3.0B
- CPRX 2.6B
- IPO Year
- BCC 2013
- CPRX 2006
- Fundamental
- Price
- BCC $77.62
- CPRX $20.84
- Analyst Decision
- BCC Buy
- CPRX Strong Buy
- Analyst Count
- BCC 7
- CPRX 5
- Target Price
- BCC $112.00
- CPRX $33.20
- AVG Volume (30 Days)
- BCC 361.9K
- CPRX 1.7M
- Earning Date
- BCC 11-03-2025
- CPRX 11-05-2025
- Dividend Yield
- BCC 7.57%
- CPRX N/A
- EPS Growth
- BCC N/A
- CPRX 183.96
- EPS
- BCC 6.82
- CPRX 1.65
- Revenue
- BCC $6,557,812,000.00
- CPRX $558,499,000.00
- Revenue This Year
- BCC N/A
- CPRX $16.51
- Revenue Next Year
- BCC $4.03
- CPRX $9.58
- P/E Ratio
- BCC $11.38
- CPRX $12.64
- Revenue Growth
- BCC N/A
- CPRX 28.55
- 52 Week Low
- BCC $75.95
- CPRX $19.05
- 52 Week High
- BCC $155.42
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- BCC 38.61
- CPRX 58.28
- Support Level
- BCC $76.71
- CPRX $19.05
- Resistance Level
- BCC $79.38
- CPRX $22.02
- Average True Range (ATR)
- BCC 2.18
- CPRX 0.60
- MACD
- BCC -0.18
- CPRX 0.16
- Stochastic Oscillator
- BCC 18.10
- CPRX 60.27
About BCC Boise Cascade L.L.C.
Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams. In addition, it manufactures structural, appearance, and industrial-grade plywood panels, and ponderosa pine lumber. The Building Materials Distribution segment is engaged in the distribution of various building materials, including oriented strand board (OSB), plywood, and lumber; general line items such as siding, composite decking, doors and millwork, metal products, roofing, and insulation; and EWP, among others. The company generates a majority of its revenue from the Building Material Distribution segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).